Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

QR Code

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

Background: Approximately 826,000 children, mostly young infants, die annually from invasive pneumococcal disease. A 6-10-14-week schedule of pneumococcal conjugate vaccine (PCV) is efficacious but neonatal PCV may provide earlier protection and better coverage. We conducted an open randomized contr...

Full description

Bibliographic Details
Main Authors:	Pomat, William, van den Biggelaar, Anita, Phuanukoonnon, Suparat, Francis, Jacinta, Jacoby, Peter, Siba, Peter, Alpers, Michael, Reeder, John, Holt, Patrick, Richmond, Peter, Lehmann, Deborah
Format:	Journal Article
Published:	PLOS 2013
Online Access:	http://hdl.handle.net/20.500.11937/7331

Similar Items

Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants
by: Francis, Jacinta, et al.
Published: (2009)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
by: Van Den Biggelaar, A., et al.
Published: (2017)

Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea
by: van den Biggelaar, A., et al.
Published: (2009)

PHARMACOKINETICS OF TRANSFER OF PIPERAQUINE INTO THE BREAST MILK OF PAPUA NEW GUINEAN MOTHERS
by: Moore, B., et al.
Published: (2015)

Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
by: Giele, C., et al.
Published: (2007)

Emerging possibilities and constraints to Papua New Guinean smallholder coffee producers entering the speciality coffee market
by: Murray-Prior, Roy, et al.
Published: (2007)

Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria
by: Salman, S., et al.
Published: (2011)

Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women
by: Moore, B., et al.
Published: (2016)

Pneumococcal conjugate vaccine implementation in middle-income countries
by: Tricarico, Serena, et al.
Published: (2017)

Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria
by: Salman, S., et al.
Published: (2012)

Meningeal inflammation increases cerebrospinal fluid artemether concentrations in Papua New Guinean children treated with intramuscular artemether
by: Manning, L., et al.
Published: (2011)

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria
by: Karl, S., et al.
Published: (2016)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
by: Laman, M., et al.
Published: (2014)

Effect of coadministered fat on the tolerability, safety and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria
by: Moore, Brioni, et al.
Published: (2014)

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women
by: Benjamin, J., et al.
Published: (2015)

Anti-inflammatory and antibacterial effects of kinos from Australian and Papua New Guinean Eucalyptus species
by: Mungkaje, Martha Yahimbu
Published: (2015)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
by: Laman, M., et al.
Published: (2014)

In vitro immunogenic and immunostimulatory effects of zwitterionized 23-valent pneumococcal polysaccharide vaccine compared with nonzwitterionized vaccine.
by: Abdulamir, Ahmed Sahib, et al.
Published: (2010)

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: A six months post-treatment follow-up study
by: Laman, M., et al.
Published: (2015)

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: Feasibility of abbreviated high-dose regimens for radical cure of vivax malaria
by: Moore, Brioni, et al.
Published: (2014)

The role of biomedical research in the fight against pneumonia in Papua New Guinea
by: Greenhill, A., et al.
Published: (2010)

Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
by: Mukap, M., et al.
Published: (2018)

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Moore, Brioni, et al.
Published: (2017)

An evaluation of patients’ adherence with hypoglycemic medications among Papua New Guineans with Type 2 Diabetes: Influencing factors
by: Pihau-Tulo, Stella, et al.
Published: (2014)

Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine
by: Strachan, R., et al.
Published: (2013)

Development of a Papua New Guinean onshore carbonate reservoir: A comparative borehole image (FMI) and petrographic evaluation
by: Wilson, Moyra, et al.
Published: (2013)

Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia
by: Gidding, H., et al.
Published: (2018)

Pneumococcal infections
by: Jamal, Farida, et al.
Published: (2013)

Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations
by: van den Biggelaar, A., et al.
Published: (2009)

National news agency in Papua New Guinea
by: Henshall, Peter
Published: (1988)

Invasive pneumococcal disease in WA: emergence of replacement serotype 19A
by: Giele, C., et al.
Published: (2009)

An expert system for pneumococcal prognosis
by: Othman, Nurnadzirah, et al.
Published: (2018)

Otitis-prone children produce functional antibodies to pneumolysin and pneumococcal polysaccharides.
by: Kirkham, L., et al.
Published: (2017)

Otitis-prone children produce functional antibodies to pneumolysin and pneumococcal polysaccharides
by: Kirkham, L., et al.
Published: (2017)

Plasmodium Vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea
by: Genton, B., et al.
Published: (2008)

The first 50 years of the Papua New Guinea Medical Journal: a celebration of its Golden Jubilee
by: Alpers, Michael
Published: (2005)

Serological evidence for transmission of multiple dengue virus serotypes in Papua New Guinea and West Papua prior to 1963
by: Luang-Suarkia, D., et al.
Published: (2017)

Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission
by: Arnott, A., et al.
Published: (2014)

National Policy for an Integrated Health System and Local Implementation: The Case of Papua New Guinea and the Nasoi
by: Macfarlane, Joan, et al.
Published: (2010)

Chlamydia trachomatis infection and distribution of serovars in the Eastern Highlands Province, Papua New Guinea
by: Suarkia, D., et al.
Published: (2007)